Israel Lowy

23.4k citations
159 papers · 11.1k indexed · 7 hit papers · h-index 41
Topics
Cancer Immunotherapy and Biomarkers (85 papers)CAR-T cell therapy research (52 papers)Immunotherapy and Immune Responses (32 papers)

In The Last Decade

Israel Lowy

154 papers receiving 10.8k citations

Hit Papers

Phase I Study of Single-Agent Anti–Programmed Death-1 (MD...20062026201220192010201020062010200750010001.5k2.0k

Peers

Israel Lowy
Comparison fields: 5 of 104
  • Oncology 6.9k
  • Immunology 4.7k
  • Molecular Biology 2.0k
  • Infectious Diseases 1.8k
  • Pulmonary and Respiratory Medicine 1.7k
Replace Esteban Celis with:
Esteban Celis United States
Howard L. Kaufman United States
Douglas J. Schwartzentruber United States
Sjoerd H. van der Burg Netherlands
Stuart G. Tangye Australia
Michael Stürzl Germany
Philip D. Greenberg United States
Mary Keir United States
Susan E. Krown United States
Richard F. Ambinder United States
Israel Lowy relative to Esteban Celis United States Esteban Celis's profile →
Citations per field
00.5×2.8×
Esteban Celis · 1×
Citations per year

Countries citing papers authored by Israel Lowy

Since Specialization
Citations

This map shows the geographic impact of Israel Lowy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Israel Lowy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Israel Lowy more than expected).

Fields of papers citing papers by Israel Lowy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Israel Lowy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Israel Lowy. The network helps show where Israel Lowy may publish in the future.

Co-authorship network of co-authors of Israel Lowy

This figure shows the co-authorship network connecting the top 25 collaborators of Israel Lowy. A scholar is included among the top collaborators of Israel Lowy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Israel Lowy. Israel Lowy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 7
4 1
5 1
6 3
7 5
8 1
9 31
10 11
11 7
12 31
13 161
14 50
15 47
16 59
17 263
18 110
19
Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4breakdown →
646
20 2

About Israel Lowy

Israel Lowy is a scholar working on Oncology, Immunology and Virology, having authored 159 papers that have together received 11.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (85 papers), CAR-T cell therapy research (52 papers) and Immunotherapy and Immune Responses (32 papers). The work is most often cited by research in Oncology (6.9k citations), Immunology (4.7k citations) and Virology (977 citations). Israel Lowy has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include Suzanne L. Topalian, Marybeth S. Hughes, Richard M. Sherry, Richard E. Royal, Udai S. Kammula, Steven A. Rosenberg, Elizabeth Stankevich, Alan J. Korman, Catherine Lévy and Joel Picus. Their work appears in journals such as Science, New England Journal of Medicine and Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026